• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

眼神经肽

Ocular neuropeptides.

作者信息

Tervo T, Tervo K, Eränkö L

出版信息

Med Biol. 1982 Apr;60(2):53-60.

PMID:6178909
Abstract

This article deals with the neuropeptides found in the eye and their actions. Substance P (SP) and VIP have been found in the anterior chamber of the eye. Here SP is localized in the sensory nerves of the sclera, cornea, iris, ciliary body and ciliary processes. It is supposed to be a sensory transmitter but can also be liberated by peripheral nerve endings as a response to various trauma. When this happens in the eye, for instance, after irritation of the Vth cranial nerve, SP causes an intense and long lasting miosis and may have some further actions as well. VIP has been demonstrated in nerves (probably cholinergic) of the posterior choroid and ciliary body. It is a potent vasodilator and may regulate choroideal blood flow. The retina is especially rich in different neuropeptides. SP, VIP, neurotensin, enkephalin, somatostatin, glucagon and gonadotropin-releasing hormone have all been demonstrated in the inner plexiform layer of the retina of various animal species. Specific information about the physiological role of retinal neuropeptides is still scarce but research is in progress. Considering the clinical significance of the new information about ocular neuropeptides, SP seems to be the most important substance. Recently a synthetic SP antagonist was reported to block the inflammatory response in the rabbit eye, which suggests a clinical use for this type of compounds.

摘要

本文论述了在眼睛中发现的神经肽及其作用。P物质(SP)和血管活性肠肽(VIP)已在眼前房中被发现。在这里,SP定位于巩膜、角膜、虹膜、睫状体和睫状突的感觉神经中。它被认为是一种感觉递质,但也可由外周神经末梢在对各种创伤的反应中释放。例如,当这种情况在眼睛中发生时,如在第五对脑神经受到刺激后,SP会引起强烈且持久的瞳孔缩小,并且可能还有一些其他作用。VIP已在脉络膜后部和睫状体的神经(可能是胆碱能神经)中被证实。它是一种强效血管舒张剂,可能调节脉络膜血流。视网膜尤其富含不同的神经肽。SP、VIP、神经降压素、脑啡肽、生长抑素、胰高血糖素和促性腺激素释放激素在各种动物物种的视网膜内丛状层中均已被证实。关于视网膜神经肽生理作用的具体信息仍然很少,但研究正在进行中。考虑到有关眼神经肽新信息的临床意义,SP似乎是最重要的物质。最近有报道称一种合成的SP拮抗剂可阻断兔眼的炎症反应,这表明这类化合物具有临床应用价值。

相似文献

1
Ocular neuropeptides.眼神经肽
Med Biol. 1982 Apr;60(2):53-60.
2
Neuropeptides modulate immune deviation induced via the anterior chamber of the eye.
J Immunol. 1995 Aug 15;155(4):1746-56.
3
Distribution of calcitonin-gene-related peptide, neuropeptide-Y, vasoactive intestinal polypeptide, cholecystokinin-8, substance P and islet peptides in the pancreas of normal and diabetic rats.正常大鼠和糖尿病大鼠胰腺中降钙素基因相关肽、神经肽Y、血管活性肠多肽、胆囊收缩素-8、P物质及胰岛肽的分布
Neuropeptides. 1999 Jun;33(3):227-35. doi: 10.1054/npep.1999.0022.
4
[Brain and intestinal peptides and endocrinological tests].[脑与肠肽及内分泌学检测]
Rinsho Byori. 1984 Jan;Spec No 58:62-77.
5
Peptidergic innervation of the rat cornea.大鼠角膜的肽能神经支配
Exp Eye Res. 1998 Apr;66(4):421-35. doi: 10.1006/exer.1997.0446.
6
Mediation of the ocular response to injury and irritation: peptides versus prostaglandins.眼部对损伤和刺激反应的调节:肽类与前列腺素
Prog Clin Biol Res. 1989;312:293-328.
7
Ontogeny of neurohormonal peptides, serotonin, and nitric oxide synthase in the gastrointestinal neuroendocrine system of the axolotl (Ambystoma mexicanum): an immunohistochemical analysis.墨西哥钝口螈(Ambystoma mexicanum)胃肠神经内分泌系统中神经激素肽、5-羟色胺和一氧化氮合酶的个体发生:免疫组织化学分析
Gen Comp Endocrinol. 2001 Jan;121(1):74-83. doi: 10.1006/gcen.2000.7568.
8
[Ocular inflammation and neuropeptides in rabbit ocular tissue. Report 1. Measurement of neuropeptide in rabbit ocular tissue].
Nippon Ganka Gakkai Zasshi. 1988 Mar;92(3):448-52.
9
[Purinergic (P-type, nonadrenergic, noncholinergic) or peptidergic nerves?].[嘌呤能(P 型,非肾上腺素能,非胆碱能)神经还是肽能神经?]
Fiziol Zh SSSR Im I M Sechenova. 1984 May;70(5):641-8.
10
Neuropeptides contained in peripheral cardiovascular nerves.外周心血管神经中含有的神经肽。
Clin Exp Hypertens A. 1984;6(1-2):91-106. doi: 10.3109/10641968409062553.

引用本文的文献

1
Immunomodulatory Role of Neuropeptides in the Cornea.神经肽在角膜中的免疫调节作用。
Biomedicines. 2022 Aug 16;10(8):1985. doi: 10.3390/biomedicines10081985.
2
Role of the Neurokinin-1 Receptor in the Promotion of Corneal Epithelial Wound Healing by the Peptides FGLM-NH2 and SSSR in Neurotrophic Keratopathy.神经激肽-1 受体在 FGLM-NH2 和 SSSR 肽促进神经营养性角膜病变角膜上皮愈合中的作用。
Invest Ophthalmol Vis Sci. 2020 Jul 1;61(8):29. doi: 10.1167/iovs.61.8.29.
3
Corneal re-innervation following refractive surgery treatments.
屈光手术治疗后的角膜再神经支配
Neural Regen Res. 2019 Apr;14(4):557-565. doi: 10.4103/1673-5374.247421.
4
Purinergic receptors in ocular inflammation.眼部炎症中的嘌呤能受体
Mediators Inflamm. 2014;2014:320906. doi: 10.1155/2014/320906. Epub 2014 Jul 14.
5
Neuropeptides and diabetic retinopathy.神经肽与糖尿病视网膜病变。
Br J Clin Pharmacol. 2013 May;75(5):1189-201. doi: 10.1111/bcp.12003.
6
Retinal laser burn-induced neuropathy leads to substance P-dependent loss of ocular immune privilege.视网膜激光灼伤诱导的神经病变导致 P 物质依赖性眼免疫特惠丧失。
J Immunol. 2012 Aug 1;189(3):1237-42. doi: 10.4049/jimmunol.1103264. Epub 2012 Jun 27.
7
Diabetic keratopathy and treatment by modulation of the opioid growth factor (OGF)-OGF receptor (OGFr) axis with naltrexone: a review.糖尿病性角膜病变及其通过阿片样生长因子 (OGF)-OGF 受体 (OGFr) 轴调节剂(纳曲酮)的治疗:综述。
Brain Res Bull. 2010 Feb 15;81(2-3):236-47. doi: 10.1016/j.brainresbull.2009.08.008. Epub 2009 Aug 14.
8
Vasoactive neuropeptides in clinical ophthalmology: An association with autoimmune retinopathy?临床眼科中的血管活性神经肽:与自身免疫性视网膜病变有关联吗?
Clin Ophthalmol. 2009;3:259-61. doi: 10.2147/opth.s5356. Epub 2009 Jun 2.
9
Does autoimmunity of endogenous vasoactive neuropeptides cause retinopathy in humans?内源性血管活性神经肽的自身免疫会导致人类视网膜病变吗?
Med Hypotheses. 2008;70(1):137-40. doi: 10.1016/j.mehy.2007.04.016. Epub 2007 Jun 7.
10
Enkephalin immunoreactivity in iris nerves: distribution in normal and grafted irides, persistence and enhanced fluorescence after denervations.虹膜神经中的脑啡肽免疫反应性:在正常和移植虹膜中的分布、去神经支配后的持续存在及荧光增强
Histochemistry. 1984;80(1):1-7. doi: 10.1007/BF00492763.